Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5.
about
Adenoviral transduction of enterocytes and M-cells using in vitro models based on Caco-2 cells: the coxsackievirus and adenovirus receptor (CAR) mediates both apical and basolateral transductionIdentification of the Receptor Binding Domain of the Mouse Mammary Tumor Virus Envelope ProteinCell entry and trafficking of human adenovirus bound to blood factor X is determined by the fiber serotype and not hexon:heparan sulfate interactionOptimizing atoh1-induced vestibular hair cell regeneration.Improved gene delivery to intestinal mucosa by adenoviral vectors bearing subgroup B and d fibers.Mechanism of ad5 vaccine immunity and toxicity: fiber shaft targeting of dendritic cells.Defining a Novel Role for the Coxsackievirus and Adenovirus Receptor in Human Adenovirus Serotype 5 Transduction In Vitro in the Presence of Mouse Serum.Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNSAdenovirus receptors.Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activationAdenovirus receptors and their implications in gene deliveryp21 Promotes oncolytic adenoviral activity in ovarian cancer and is a potential biomarker.Imaging chemically modified adenovirus for targeting tumors expressing integrin alphavbeta3 in living mice with mutant herpes simplex virus type 1 thymidine kinase PET reporter gene.Interaction between mouse adenovirus type 1 and cell surface heparan sulfate proteoglycans.Subgroup B and F fiber chimeras eliminate normal adenovirus type 5 vector transduction in vitro and in vivo.Mutation of the fiber shaft heparan sulphate binding site of a 5/3 chimeric adenovirus reduces liver tropism.Retargeting adenoviral vectors to improve gene transfer into tumorsTerminal N-linked galactose is the primary receptor for adeno-associated virus 9.Targeting gene therapy vectors to the vascular endothelium.Fiber and penton base capsid modifications yield diminished adenovirus type 5 transduction and proinflammatory gene expression with retention of antigen-specific humoral immunity.Novel fiber-dependent entry mechanism for adenovirus serotype 5 in lacrimal aciniHomotrimeric, beta-stranded viral adhesins and tail proteinsDevelopment of a novel surrogate virus for human T-cell leukemia virus type 1: inhibition of infection by osteoprotegerin.Bovine lactoferrin inhibits Toscana virus infection by binding to heparan sulphateGene therapy progress and prospects: adenoviral vectors.Bovine lactoferrin inhibits adenovirus infection by interacting with viral structural polypeptidesThe genomic sequence of the Chinese hamster ovary (CHO)-K1 cell lineThe transduction of Coxsackie and Adenovirus Receptor-negative cells and protection against neutralizing antibodies by HPMA-co-oligolysine copolymer-coated adenovirusTransductional targeting of adenovirus vectors for gene therapyPeptide targeting of adenoviral vectors to augment tumor gene transferIdentification of HI-like loop in CELO adenovirus fiber for incorporation of receptor binding motifs.Adenoviruses for treatment of cancer.A heparan sulfate-targeted conditionally replicative adenovirus, Ad5.pk7-Delta24, for the treatment of advanced breast cancer.Fiber shaft-chimeric adenovirus vectors lacking the KKTK motif efficiently infect liver cells in vivoStrategies to enhance transductional efficiency of adenoviral-based gene transfer to primary human fibroblasts and keratinocytes as a platform in dermal woundsCurrent advances and future challenges in Adenoviral vector biology and targetingOncolytic adenoviruses as antiglioma agents.Biochemistry and pathophysiology of intravascular and intracellular lipolysis.T-cell immunity generated by recombinant adenovirus vaccines.Novel vectors for in vivo gene delivery to vascular tissue.
P2860
Q24303580-34A104E2-8648-4332-91BF-D8630E70C399Q27485665-0BBD9601-6945-4D8D-AFB8-4D1876E52AD0Q28744246-D0F072A0-408F-4DE9-B16C-6496C81E0EA3Q30364993-B2FD414D-1ADA-4230-B76A-545A3B1592B0Q33234748-906D1C4F-B6C6-44FA-8357-637C969B605DQ33275292-75D7E57A-D7F4-460A-B758-0DB5F8060EF2Q33440718-E9ABE026-C324-4F98-9843-4517A4941E6BQ33894621-CE173ACD-D7CA-4F1C-B090-C564268986CDQ33984229-D395E63F-3539-44EB-8860-658E14B925DAQ33987398-8F781C0D-ACC1-4322-A875-B7559EC5D960Q33994011-7BB96D33-443A-4827-99C1-7091FB0C59FBQ33997928-AFE793DB-3D99-4CD7-86B8-124FAF6B9D3EQ34134316-18D84F59-4FF0-4E9C-A907-1CA013100B31Q34162849-334C91FC-ACDB-4C7F-B5D9-5D005ABB890EQ34465133-D6009CF8-B74E-47FB-8B61-55A551054BC1Q34667746-D0D575A8-7B76-4C75-96DF-9C9BE7A22D07Q34699410-0EE0B6F8-A1F0-4620-9A24-253D3C766D31Q34787342-9103AD5D-7C06-4A54-A57A-AFE1C01D0F77Q35095393-BFD0FCF1-6260-4707-B42C-06F616EC04FCQ35139196-7A34FDCB-0B87-4E18-B70F-C6D337335FB9Q35140019-C26D9591-3F70-4E5A-8F29-BA00B78432F7Q35151460-E2D5FD59-33BE-4EA5-88DF-A60E5777634CQ35155045-82D8C8A4-5842-4CBC-9FC2-EE9124333C3AQ35159976-58C30990-293A-48B3-B854-A2ED1C5313A7Q35165719-B40EFCF8-79EA-4439-8983-D3A1E3B852F3Q35166195-548044F8-2D1C-4644-BD94-FCB38EBF4C4FQ35188192-DB17820A-BB73-47A3-A89B-EAE2F9FEBBC6Q35300626-07F929A1-2457-47FF-B72A-D8F7A46EFC81Q35609035-D7D41B00-65F7-4E6B-83D1-85EE67740EC7Q36049440-4F90BF4C-18C1-4CC2-801F-453418748274Q36098980-30CEA059-B474-465F-A40B-5FD8117949FDQ36132288-51BB0379-56A0-4F3E-893F-60A3C5C704A9Q36158701-E76C47A6-E87E-4564-B0DB-F81CBC08BAC7Q36315434-8C5B6710-F199-4C87-86B7-87B77AA14888Q36387908-585DE3F1-3E20-460A-960B-47197A2129A3Q36463004-838491C6-A971-44D3-A841-990B5DC7539BQ36499227-36002DE1-96DD-4776-9C8F-14594B03D102Q36708030-237D7E72-831F-4807-B22A-959D573C27E9Q36837129-C5012F2E-BDB9-4854-9231-A070A1B97D0AQ36842711-0D7623BB-DAA0-44EA-9561-B43120A0F836
P2860
Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Heparan sulfate glycosaminogly ...... g of adenovirus types 2 and 5.
@en
Heparan sulfate glycosaminogly ...... g of adenovirus types 2 and 5.
@nl
type
label
Heparan sulfate glycosaminogly ...... g of adenovirus types 2 and 5.
@en
Heparan sulfate glycosaminogly ...... g of adenovirus types 2 and 5.
@nl
prefLabel
Heparan sulfate glycosaminogly ...... g of adenovirus types 2 and 5.
@en
Heparan sulfate glycosaminogly ...... g of adenovirus types 2 and 5.
@nl
P2093
P2860
P1433
P1476
Heparan sulfate glycosaminogly ...... ng of adenovirus types 2 and 5
@en
P2093
A Bonizzato
M Santacatterina
P2860
P304
P356
10.1128/JVI.75.18.8772-8780.2001
P407
P577
2001-09-01T00:00:00Z